Skip to main content
Equibles

Affinity Asset Advisors, LLC

Position in IBIO — iBio, Inc.

CIK 1773195 NEW YORK, NY
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,013,791
+$1,110,111 QoQ
Shares Held
4,007,881
+29.0% QoQ
Ownership
6.23%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1
of 55 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. IBIO ranks #52 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 3,750,000 $132,712,500
2 APGE
Apogee Therapeutics, Inc.
 987,000 $131,004,510
3 SYRE
Spyre Therapeutics, Inc.
 1,279,134 $113,561,516
4 XENE
Xenon Pharmaceuticals Inc.
 1,595,000 $96,274,200
5 ERAS
Erasca, Inc.
 5,250,000 $96,180,000
6 INSM
INSMED Inc
 650,000 $69,303,000
7 PRAX
Praxis Precision Medicines, Inc.
 185,000 $61,936,150
8 ORKA
Oruka Therapeutics, Inc.
 590,000 $56,150,300

All Filings in IBIO

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,013,791 4,007,881
2026-03-31 $5,903,680 3,107,200
2025-12-31 $3,970,396 2,057,200